These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32760211)

  • 1. Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.
    Zheng X; Peng Q; Wang L; Zhang X; Huang L; Wang J; Qin Z
    Int J Biol Sci; 2020; 16(13):2442-2453. PubMed ID: 32760211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer.
    Sharma S; Mittal M; Shukla A; Khan J; Dinand V; Saluja D
    BMC Cancer; 2024 Sep; 24(1):1094. PubMed ID: 39227899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR proteins in cancer: function, regulation, and small inhibitor.
    Bei M; Xu J
    Cell Mol Biol Lett; 2024 May; 29(1):78. PubMed ID: 38778254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.
    Li D; Yu W; Lai M
    Drug Discov Today; 2023 Sep; 28(9):103691. PubMed ID: 37385370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the expression and stability of full-length and truncated SRSF3 proteins in human cancer cells.
    Sue SH; Liu ST; Huang SM
    Sci Rep; 2024 Jun; 14(1):14397. PubMed ID: 38909100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone.
    Buoso E; Galasso M; Ronfani M; Serafini MM; Lanni C; Corsini E; Racchi M
    Pharmacol Res; 2017 Jun; 120():180-187. PubMed ID: 28373129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
    Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
    J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
    Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
    Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m(6)A: Signaling for mRNA splicing.
    Adhikari S; Xiao W; Zhao YL; Yang YG
    RNA Biol; 2016 Sep; 13(9):756-9. PubMed ID: 27351695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics and clinical implications of serine/arginine-rich splicing factors in human cancer.
    Zhang J; Fang Z; Song C
    Aging (Albany NY); 2023 Nov; 15(22):13287-13311. PubMed ID: 38015716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms.
    Wan L; Deng M; Zhang H
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
    Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
    Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.
    Marques DS; Grativol J; Alves da Silva Peres R; da Rocha Matos A; Gimba ERP
    Tumour Biol; 2017 Sep; 39(9):1010428317725442. PubMed ID: 28936921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
    Tang J; Xie Y; Huang J; Zhang L; Jiang W; Li Z; Bian J
    Bioorg Med Chem; 2022 Sep; 70():116921. PubMed ID: 35863237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1.
    Aubol BE; Serrano P; Fattet L; Wüthrich K; Adams JA
    J Biol Chem; 2018 Oct; 293(43):16751-16760. PubMed ID: 30185622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
    Yang S; Jia R; Bian Z
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effect of SRSF9 overexpression on HIV-1 production.
    Kim GN; Yu KL; Kim HI; You JC
    BMB Rep; 2022 Dec; 55(12):639-644. PubMed ID: 36330710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRp20: A potential therapeutic target for human tumors.
    Wang H; Jiang Y
    Pathol Res Pract; 2021 Aug; 224():153444. PubMed ID: 34126370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5-diamino-6-chloro-N-(N-(2,6-dichlorobenzoyl)carbamimidoyl)pyrazine-2-carboxide.
    Lee CC; Chang WH; Chang YS; Yang JM; Chang CS; Hsu KC; Chen YT; Liu TY; Chen YC; Lin SY; Wu YC; Chang JG
    Mol Oncol; 2019 Aug; 13(8):1744-1762. PubMed ID: 31152681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.